Loading provider…
Loading provider…
Hematology & Oncology Physician in Hilton Head Island, SC
NPI: 1043218316Primary Practice Location
South Carolina Cancer Specialists
45 Hospital Center Cmn, Hilton Head Island, SC
Primary Employer
South Carolina Cancer Specialists
sjcphysiciannetwork.com
HQ Phone
Get MD Gary's Phone Numberphone_androidMobile
Get MD Gary's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardGA State Medical License
SC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 861 | 1,659 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 777 | 2,286 |
| 3 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 354 | 1,193 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 199 | 200 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 188 | 271 |
Authors: Satish Shah, Danelle James, George Cole, Ramesh Ramanathan
Journal: Oncology
Publication Date: 2019-03-07
Authors: Gascón, Pere, Nagarkar, Rajnish, Šmakal, Martin, Syrigos, Konstantinos N, Barrios, Carlos H, Sánchez, Jesús Cárdenas, Zhang, Li, Henry, David H, Gordon, David, Hirsh, Vera, Kubota, Kaoru, Orlov, Sergey, Thomas, Gary, Steinmetz, Tilman, Kang, Jin-Hyoung, Tomita, Dianne K, Fleishman, Alexander N, Park, Joseph K, De Oliveira Brandao, Cisio
Journal: J Thorac Oncol
Publication Date: 2019-10-16
Lead Sponsor: Bristol-Myers Squibb
Lead Sponsor: BrightPath Biotherapeutics
Intervention / Treatment: BIOLOGICAL: GRN-1201 + Pembrolizumab
Lead Sponsor: Eli Lilly and Company
Collaborators: Alzheimer's Therapeutic Research Institute
Intervention / Treatment: DRUG: Placebo, DRUG: Solanezumab